These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 19783716)

  • 21. Alpha-1 antitrypsin deficiency in emphysema.
    Khan H; Salman KA; Ahmed S
    J Assoc Physicians India; 2002 Apr; 50():579-82. PubMed ID: 12164415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies.
    Crowther DC; Belorgey D; Miranda E; Kinghorn KJ; Sharp LK; Lomas DA
    Eur J Hum Genet; 2004 Mar; 12(3):167-72. PubMed ID: 14694355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha-1 antitrypsin deficiency 50 years later].
    Mornex JF
    Bull Acad Natl Med; 2014; 198(4-5):757-66. PubMed ID: 26753407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 1-antitrypsin deficiency and the impact of nursing interventions and treatment with intravenous therapy. An overview.
    Scharnweber K
    J Intraven Nurs; 1999; 22(5):258-64. PubMed ID: 10776189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia.
    Lomas DA; Lourbakos A; Cumming SA; Belorgey D
    Biochem Soc Trans; 2002 Apr; 30(2):89-92. PubMed ID: 12023831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
    Blank CA; Brantly M
    Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The alpha-1 antitrypsin deficiency: advances in knowledge and unsolved questions].
    Cuvelier A; Mornex JF
    Rev Mal Respir; 2014 Apr; 31(4):295-9. PubMed ID: 24750949
    [No Abstract]   [Full Text] [Related]  

  • 31. Alpha 1-antitrypsin deficiency.
    Ellett ML
    Gastroenterol Nurs; 1991 Dec; 14(3):138-41. PubMed ID: 1760450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha one antitrypsin deficiency: from gene to treatment.
    Wood AM; Stockley RA
    Respiration; 2007; 74(5):481-92. PubMed ID: 17671403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From gene disease; alpha1-antitrypsine deficiency].
    Hiemstra PS; Stolk J
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):758-60. PubMed ID: 12731467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
    Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha(1)-antitrypsin deficiency, liver disease and emphysema.
    Parfrey H; Mahadeva R; Lomas DA
    Int J Biochem Cell Biol; 2003 Jul; 35(7):1009-14. PubMed ID: 12672469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-1-antitrypsin deficiency.
    Bals R
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of alpha 1-antitrypsin deficiency with lung and liver diseases.
    Resendes M
    West J Med; 1987 Jul; 147(1):48-53. PubMed ID: 3321708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
    Louie SG; Sclar DA; Gill MA
    Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.